Cargando…

Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells

The B16F10 murine melanoma cell line displays a low expression of MHC class I molecules favoring immune evasion and metastases in immunocompetent C57 BL/6 wild-type mice. Here, we generated metastases to the liver, an organ that is skewed towards immune tolerance, by intrasplenic injection of B16F10...

Descripción completa

Detalles Bibliográficos
Autores principales: Foerster, Friedrich, Boegel, Sebastian, Heck, Rosario, Pickert, Geetha, Rüssel, Nina, Rosigkeit, Sebastian, Bros, Matthias, Strobl, Stephanie, Kaps, Leonard, Aslam, Misbah, Diken, Mustafa, Castle, John, Sahin, Ugur, Tuettenberg, Andrea, Bockamp, Ernesto, Schuppan, Detlef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889278/
https://www.ncbi.nlm.nih.gov/pubmed/29632723
http://dx.doi.org/10.1080/2162402X.2017.1409929
_version_ 1783312676638687232
author Foerster, Friedrich
Boegel, Sebastian
Heck, Rosario
Pickert, Geetha
Rüssel, Nina
Rosigkeit, Sebastian
Bros, Matthias
Strobl, Stephanie
Kaps, Leonard
Aslam, Misbah
Diken, Mustafa
Castle, John
Sahin, Ugur
Tuettenberg, Andrea
Bockamp, Ernesto
Schuppan, Detlef
author_facet Foerster, Friedrich
Boegel, Sebastian
Heck, Rosario
Pickert, Geetha
Rüssel, Nina
Rosigkeit, Sebastian
Bros, Matthias
Strobl, Stephanie
Kaps, Leonard
Aslam, Misbah
Diken, Mustafa
Castle, John
Sahin, Ugur
Tuettenberg, Andrea
Bockamp, Ernesto
Schuppan, Detlef
author_sort Foerster, Friedrich
collection PubMed
description The B16F10 murine melanoma cell line displays a low expression of MHC class I molecules favoring immune evasion and metastases in immunocompetent C57 BL/6 wild-type mice. Here, we generated metastases to the liver, an organ that is skewed towards immune tolerance, by intrasplenic injection of B16F10 cells in syngeneic C57 BL/6 compared to allogeneic Balb/c mice. Surprisingly, Balb/c mice, which usually display a pronounced M2 macrophage and Th2 T cell polarization, were ∼3 times more susceptible to metastasis than C57 BL/6 mice, despite a much higher M1 and Th1 T cell immune response. The anti-metastatic advantage of C57 BL/6 mice could be attributed to a more potent NK-cell mediated cytotoxicity against B16F10 cells. Our findings highlight the role of NK cells in innate anti-tumor immunity in the context of the liver – particularly against highly aggressive MHC I-deficient cancer cells. Moreover, the B16F10 model of melanoma liver metastasis is suited for developing novel therapies targeting innate NK cell related immunity in liver metastases and liver cancer.
format Online
Article
Text
id pubmed-5889278
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-58892782018-04-09 Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells Foerster, Friedrich Boegel, Sebastian Heck, Rosario Pickert, Geetha Rüssel, Nina Rosigkeit, Sebastian Bros, Matthias Strobl, Stephanie Kaps, Leonard Aslam, Misbah Diken, Mustafa Castle, John Sahin, Ugur Tuettenberg, Andrea Bockamp, Ernesto Schuppan, Detlef Oncoimmunology Original Research The B16F10 murine melanoma cell line displays a low expression of MHC class I molecules favoring immune evasion and metastases in immunocompetent C57 BL/6 wild-type mice. Here, we generated metastases to the liver, an organ that is skewed towards immune tolerance, by intrasplenic injection of B16F10 cells in syngeneic C57 BL/6 compared to allogeneic Balb/c mice. Surprisingly, Balb/c mice, which usually display a pronounced M2 macrophage and Th2 T cell polarization, were ∼3 times more susceptible to metastasis than C57 BL/6 mice, despite a much higher M1 and Th1 T cell immune response. The anti-metastatic advantage of C57 BL/6 mice could be attributed to a more potent NK-cell mediated cytotoxicity against B16F10 cells. Our findings highlight the role of NK cells in innate anti-tumor immunity in the context of the liver – particularly against highly aggressive MHC I-deficient cancer cells. Moreover, the B16F10 model of melanoma liver metastasis is suited for developing novel therapies targeting innate NK cell related immunity in liver metastases and liver cancer. Taylor & Francis 2017-12-26 /pmc/articles/PMC5889278/ /pubmed/29632723 http://dx.doi.org/10.1080/2162402X.2017.1409929 Text en © 2018 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Original Research
Foerster, Friedrich
Boegel, Sebastian
Heck, Rosario
Pickert, Geetha
Rüssel, Nina
Rosigkeit, Sebastian
Bros, Matthias
Strobl, Stephanie
Kaps, Leonard
Aslam, Misbah
Diken, Mustafa
Castle, John
Sahin, Ugur
Tuettenberg, Andrea
Bockamp, Ernesto
Schuppan, Detlef
Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells
title Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells
title_full Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells
title_fullStr Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells
title_full_unstemmed Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells
title_short Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells
title_sort enhanced protection of c57 bl/6 vs balb/c mice to melanoma liver metastasis is mediated by nk cells
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889278/
https://www.ncbi.nlm.nih.gov/pubmed/29632723
http://dx.doi.org/10.1080/2162402X.2017.1409929
work_keys_str_mv AT foersterfriedrich enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT boegelsebastian enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT heckrosario enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT pickertgeetha enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT russelnina enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT rosigkeitsebastian enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT brosmatthias enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT stroblstephanie enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT kapsleonard enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT aslammisbah enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT dikenmustafa enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT castlejohn enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT sahinugur enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT tuettenbergandrea enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT bockampernesto enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells
AT schuppandetlef enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells